OBJECTIVE: To determine the relationship between @entity323 and @entity209 ( @entity209 ) in @entity1 with @entity1067 ( @entity1067 ) and lower urinary tract symptoms (LUTS). MATERIAL AND METHODS: Seventy-eight @entity1 who were admitted to our outpatient clinic because of @entity1067 -related LUTS over 40 years of age were included in the study. @entity1 with LUTS and @entity323 ( @entity323 ) were evaluated by International Prostate Symptom Score (IPSS) and International Index of Erectile Function-5 (IIEF-5) forms. The National @entity165 Education Program Adult Treatment Panel III criteria was used for the diagnosis of @entity209 . LUTS were classified as mild, moderate, and severe according to IPSS and @entity323 was classified as mild- moderate, moderate, and severe according to the IIEF-5. For the evaluation of data, descriptive statistical methods (mean, standard deviation, median, frequency, ratio, minimum, and maximum) and also for the comparison of the variables with non-normal distribution in 3 or more than 3 groups Student's t test, Mann-Whitney U, ANOVA, chi-square, Fisher Exact tests, and Pearson correlation analysis were used. P<0.05 was accepted as the level of statistical significance. RESULTS: Mean age of the @entity1 included in the study was 61.83  9.15. In 34.6% of the @entity1 with @entity209 , 70.5% of the @entity1 with @entity323 and 37.2% of the @entity1 with severe LUTS were determined. There were no significant differences between the mean age of @entity1 with and without @entity209 (p>0.05). There was a positive correlation with age and severity of LUTS but this relationship was not found to be statistically significant (p>0.05). Mean age of the @entity1 with @entity323 was significantly higher than those without (p<0.001). A statistically significant relationship was not observed between the mean IPSS scores and the severity of LUTS with Mets. However, we observed a weakly positive correlation between @entity412 levels and IPSS. Mean IIEF-5 scores of the @entity1 with @entity209 were significantly lower than those of the @entity1 without @entity209 . Severity of @entity323 in the @entity1 with @entity209 was significantly higher than @entity1 without @entity209 . The percentage of @entity323 in @entity1 with severe LUTS was found to be statistically higher than other @entity1 with mild, and moderate LUTS. In addition, we found a low degree of negative correlation between IPSS and IIEF-5 scores. CONCLUSION: In @entity1 with LUTS as a consequence of @entity1067 , when severity of symptoms increases, frequency of @entity209 increases proportionally and severe @entity323 is observed much more frequently.

The relationships between @entity209 , @entity323 and lower urinary tract symptoms associated with XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity323 :: ('MESH:D007172', 'Disease') :: ['erectile dysfunction', 'ED'] @entity1067 :: ('MESH:D011470', 'Disease') :: ['benign prostatic hyperplasia', 'BPH'] @entity412 :: ('CHEBI:17855', 'Chemical') :: ['triglyceride'] @entity209 :: ('MESH:D008659', 'Disease') :: ['metabolic syndrome', 'MetS'] @entity165 :: ('MESH:D002784', 'Chemical') :: ['Cholesterol']
@entity1067 :: (MESH:D011470,Disease) :: ['benign prostatic hyperplasia']
